Literature DB >> 9073305

Early detection of cancer cachexia in the rat using 31P magnetic resonance spectroscopy of the liver and a fructose stress test.

K E Gehman1, R I Inculet, M Brauer, G D Marsh, A A Driedger, R T Thompson.   

Abstract

The dynamic metabolic effects of a fructose infusion challenge on hepatic intracellular levels of adenosine 5'-triphosphate (ATP), inorganic phosphate (Pi) and phosphomonoesters (PME) were monitored noninvasively by 31P MRS in a remote tumour-bearing rat model. Fisher male rats were inoculated with a methylcholanthrene-induced sarcoma. Seventeen rats were randomized into three groups: control (n = 6), low tumour burden (LTB, n = 6), or moderate tumour burden (MTB, n = 5). The LTB group had tumour burdens of 0.2-2.0% while the MTB group had tumour burdens of 2.6-5.7%. All rats were in the pre-clinical phase of cancer cachexia as determined by food intake and body weight. Rats were infused with 1.2 g/kg of fructose i.v. and the metabolic response of the liver was monitored with time over 1 h via 31P MRS. In all groups an immediate increase in hepatic levels of PME was noted, which returned to baseline values over the course of the experiment, reflecting the phosphorylation of fructose to fructose 1-phosphate. For the MTB rats, the return to baseline levels was more rapid than in the control or LTB group. All groups experienced a 20% decrease in hepatic ATP levels which did not return to baseline over the 1 h observation period. As well, all groups experienced an initial fall in Pi, which recovered to prefructose levels or greater. MTB rats demonstrated a 30-40% increase in Pi concentration and a 60-70% increase in Pi/ATP ratio after infusion with fructose as compared to LTB and control rats (ANOVA;p<0.05). This is consistent with cachexia-induced enhancement of hepatic gluconeogenic activity, and hence more rapid release of Pi from the phosphorylated metabolites in the MTB rats. Thus fructose infusion and hepatic 31P MRS permit pre-clinical detection of cancer cachexia as reflected by increased Pi generation and more rapid removal of PME.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9073305     DOI: 10.1002/(SICI)1099-1492(199609)9:6<271::AID-NBM421>3.0.CO;2-8

Source DB:  PubMed          Journal:  NMR Biomed        ISSN: 0952-3480            Impact factor:   4.044


  4 in total

1.  Metabolic signatures imaged in cancer-induced cachexia.

Authors:  Marie-France Penet; Mayur M Gadiya; Balaji Krishnamachary; Sridhar Nimmagadda; Martin G Pomper; Dmitri Artemov; Zaver M Bhujwalla
Journal:  Cancer Res       Date:  2011-09-26       Impact factor: 12.701

Review 2.  Understanding cancer-induced cachexia: imaging the flame and its fuel.

Authors:  Marie-France Penet; Paul T Winnard; Michael A Jacobs; Zaver M Bhujwalla
Journal:  Curr Opin Support Palliat Care       Date:  2011-12       Impact factor: 2.302

3.  The influence of tumour fluorodeoxyglucose avidity and cachexia development on patient survival in oesophageal or gastroesophageal junction cancer.

Authors:  Santiago Olaechea; Bhavani S Gannavarapu; Anne Gilmore; Christian Alvarez; Puneeth Iyengar; Rodney Infante
Journal:  JCSM Clin Rep       Date:  2021-09-05

4.  Brain metabolites in cholinergic and glutamatergic pathways are altered by pancreatic cancer cachexia.

Authors:  Paul T Winnard; Santosh Kumar Bharti; Raj Kumar Sharma; Balaji Krishnamachary; Yelena Mironchik; Marie-France Penet; Michael G Goggins; Anirban Maitra; Ihab Kamel; Karen M Horton; Michael A Jacobs; Zaver M Bhujwalla
Journal:  J Cachexia Sarcopenia Muscle       Date:  2020-10-02       Impact factor: 12.910

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.